Clinical Trial Update: Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

This report covers the safety and immunogenicity results from a Phase 1/2 trial of a TNF-α kinoid vaccine in patients with Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• TNF-α kinoid (TNF-α kinoid)

Snippet

Sponsor: Neovacs | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: COMPLETED